Latest Health News

Recce Pharmaceuticals’ RECCE 327 Topical Gel shows statistically significant superiority over standard antibiotics in treating antibiotic-resistant burn wounds in preclinical models, advancing its U.S. Department of Defense collaboration.

Platinum Asia Investments Limited has announced a special dividend of AUD 0.1992 per share, pending court approval and final confirmation post-scheme valuation. The payment is scheduled for September 2025 with a significant franked component.

Jade Gas Holdings has achieved a landmark milestone with gas flowing from its first horizontal production well in Mongolia’s Tavantolgoi CBM Project, marking a critical step toward commercial gas operations.

LGI Limited reported a robust FY25 with 14% EBITDA growth driven by expanded renewable energy capacity and carbon credit sales, while setting ambitious FY26 guidance of 25-30% EBITDA growth.

Archer Materials has partnered with Belgium’s IMEC to develop a scalable, cost-effective potassium ion biosensor using silicon semiconductor technology, aiming to accelerate commercial production by late 2025.

Tryptamine Therapeutics has locked in $2.6 million in non-dilutive funding to fast-track clinical trials of its lead psilocin-based therapy, TRP-8803, targeting binge eating disorder and other conditions.

Audeara Limited has secured a five-year licensing agreement with Eastech (Huizhou) Co., Ltd. to bring its advanced hearing technology to China’s booming medical device market, leveraging major e-commerce platforms for distribution.

Scentre Group has announced an ordinary dividend of AUD 0.08815 per security for the half-year ended 30 June 2025, payable on 29 August. The dividend is fully unfranked and includes a Dividend Reinvestment Plan with no discount.

Credit Intelligence Limited has issued a profit warning revealing a reduced loss of approximately A$4.5 million for FY25, down from A$12.5 million the previous year, driven by strategic divestments and a revenue decline.

PM Capital Global Opportunities Fund has raised its final dividend for FY25 and increased its FY26 dividend guidance to 12.5 cents fully franked, reflecting strong portfolio performance and robust earnings reserves.

Iress Limited reported a robust first half of 2025 with strong earnings growth and reduced leverage, driven by core business strength and strategic divestments. The company is poised to capitalize on regulatory tailwinds and technology demand in wealth and trading sectors.

JB Hi-Fi Limited has announced a fully franked dividend of AUD 2.05 per share for the first half of FY2025, combining ordinary and special dividends payable in September.